Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Strensiq (asfotase alfa)
pCPA File Number:
20995
Negotiation Status:
Concluded with an LOI
Indication(s):
pediatric-onset hypophosphatasia
Sponsor/Manufacturer:
Alexion Pharma GMBH
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
2017-06-07
Negotiation Process Concluded:
2018-01-09